Clinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)/PML-RARA.

  • Susanne Schnittger
  • Ulrike Bacher
  • Claudia Haferlach
  • Wolfgang Kern
  • Tamara Alpermann
  • Torsten Haferlach

Abstract

Combined treatment with all-trans-retinoic acid and chemotherapy is extremely efficient in patients with acute promyelocytic leukemia with t(15;17)/PML-RARA, but up to 15% of patients relapse.

Bibliografische Daten

OriginalspracheEnglisch
Aufsatznummer12
ISSN0390-6078
DOIs
StatusVeröffentlicht - 2011
pubmed 21859732